{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:56:02Z","timestamp":1784174162784,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1997,5]]},"DOI":"10.1007\/bf03160577","type":"journal-article","created":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T02:31:51Z","timestamp":1251167511000},"page":"S22-S25","source":"Crossref","is-referenced-by-count":17,"title":["The Riluzole Early Access Programme: descriptive analysis of 844 patients in France"],"prefix":"10.1007","volume":"244","author":[{"given":"Vincent","family":"Meininger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzague","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Zeisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03160577_CR1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mus.880121008","volume":"12","author":"CK Jablecki","year":"1989","unstructured":"Jablecki CK, Berry C, Leach J (1989) Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 12: 833\u2013841","journal-title":"Muscle Nerve"},{"key":"BF03160577_CR2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0022-510X(93)90245-T","volume":"118","author":"F Norris","year":"1993","unstructured":"Norris F, Shepherd R, Denys E, et al (1993) Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 118: 48\u201355","journal-title":"J Neurol Sci"},{"key":"BF03160577_CR3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon G, Lacomblez L, Meininger V, and the ALS\/Riluzole Study Group (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330: 585\u2013591","journal-title":"N Engl J Med"},{"key":"BF03160577_CR4","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","volume":"347","author":"L Lacomblez","year":"1996","unstructured":"Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V, for the Amyotrophic Lateral Sclerosis\/Riluzole Study Group II (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347: 1425\u20131431","journal-title":"Lancet"},{"issue":"Suppl","key":"BF03160577_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124","author":"BR Brooks","year":"1994","unstructured":"Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124 [Suppl]: 96\u2013107","journal-title":"J Neurol Sci"},{"key":"BF03160577_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0140-6736(05)64506-0","volume":"348","author":"L Lacomblez","year":"1996","unstructured":"Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V, for the Amyotrophic Lateral Sclerosis\/Riluzole Study Group II (1996) Riluzole and amyotrophic lateral sclerosis (letter). Authors\u2019 reply. Lancet 348: 337","journal-title":"Lancet"},{"key":"BF03160577_CR7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 71\u201385","journal-title":"Lancet"},{"key":"BF03160577_CR8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","volume":"335","author":"S McMahon","year":"1990","unstructured":"McMahon S, Peto R, Cutler J, et al (1990) Blood pressure, stroke, and coronary heart disease. Lancet 335: 827\u2013838","journal-title":"Lancet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03160577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03160577\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03160577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T02:36:19Z","timestamp":1558492579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03160577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":8,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["BF03160577"],"URL":"https:\/\/doi.org\/10.1007\/bf03160577","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}